At a glance
A first-of-its-kind quantitative platform for multi-organ tracking in longitudinal volumetric studies (CT/MRI/PET) for evaluating disease progression and treatment efficacy. HighRAD’s products are designed around its novel Region of Difference (ROD) generic platform and methodology for automatic, robust, and accurate lesion changes analysis in longitudinal volumetric scans, including CT and MRI scans.
Investors
Integra Holdings, QV Global Health Science Fund and 2020 HCP.
MORE COMPANIES
